National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Dictionary of Cancer Terms
In English   En español
Page Options
Print This Page
Quick Links
Director's Corner
Updates from the Director

Dictionary of Cancer Terms
Cancer-related terms

NCI Drug Dictionary
Definitions, names, and links

Funding Opportunities
Research and training

NCI Publications
Order/download free booklets

Advisory Boards and Groups
Information, meetings, reports

Science Serving People
Learn more about NCI

Español
Información en español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

NCI Responds to Hurricanes

The Nation's Investment in Cancer Research FY 2009

Cancer Trends Progress Report: 2007 Update

Past Highlights
You CAN Quit Smoking Now!
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
In English   En español

bcl-2 antisense oligodeoxynucleotide G3139 (... AN-tee-sents AH-lih-goh-NOO-klee-oh-TIDE ...)

 A substance being studied in the treatment of cancer. It may kill cancer cells by blocking the production of a protein that makes cancer cells live longer and by making them more sensitive to anticancer drugs. It is a type of antisense oligodeoxyribonucleotide. Also called oblimersen, augmerosen, and Genasense.



Previous Definitions:BBIC, BBR 2778, BBR 3464, BCG, BCG solution
Next Definitions:BCL2, BCR-ABL fusion gene, BCX-1777, BDC, Beckwith-Wiedemann syndrome

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov